Literature DB >> 21602069

Structural determinants of the alpha2 adrenoceptor subtype selectivity.

Liliana Ostopovici-Halip1, Ramona Curpăn, Maria Mracec, Cristian G Bologa.   

Abstract

Alpha2-adrenergic receptor (α2-AR) subtypes, acting mainly on the central nervous and cardiovascular systems, represent important targets for drug design, confirmed by the high number of studies published so far. Presently, only a few α2-AR subtype selective compounds are known. Using homology modeling and ligand docking, the present study analyzes the similarities and differences between binding sites, and between extracellular loops of the three subtypes of α2-ARs. Several α2-AR subtype selective ligands were docked into the active sites of the three α2-AR subtypes, key interactions between ligands and receptors were mapped, and the predicted results were compared with the available experimental data. Binding site analysis reveals a strong identity between important amino acid residues in each receptor, the very few differences being the key toward modulating selectivity of α2-AR ligands. The observed differences between binding site residues provide an excellent starting point for virtual screening of chemical databases, in order to identify potentially selective ligands for α2-ARs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602069      PMCID: PMC3307019          DOI: 10.1016/j.jmgm.2011.04.011

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  42 in total

Review 1.  Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues.

Authors:  C Saunders; L E Limbird
Journal:  Pharmacol Ther       Date:  1999-11       Impact factor: 12.310

2.  Modeling of loops in protein structures.

Authors:  A Fiser; R K Do; A Sali
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

Review 5.  Homology modeling in drug discovery: current trends and applications.

Authors:  Claudio N Cavasotto; Sharangdhar S Phatak
Journal:  Drug Discov Today       Date:  2009-05-05       Impact factor: 7.851

6.  Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study.

Authors:  Balázs Balogh; András Szilágyi; Klára Gyires; David B Bylund; Péter Mátyus
Journal:  Neurochem Int       Date:  2009-05-15       Impact factor: 3.921

7.  Homology modeling and docking evaluation of aminergic G protein-coupled receptors.

Authors:  Fiona M McRobb; Ben Capuano; Ian T Crosby; David K Chalmers; Elizabeth Yuriev
Journal:  J Chem Inf Model       Date:  2010-04-26       Impact factor: 4.956

Review 8.  In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors.

Authors:  J W Kable; L C Murrin; D B Bylund
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

9.  Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs.

Authors:  E W Willems; L F Valdivia; P R Saxena; C M Villalón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-07       Impact factor: 3.000

10.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

View more
  2 in total

1.  The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.

Authors:  Jan Anker Jahnsen; Staffan Uhlén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-07-20       Impact factor: 3.000

2.  Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.

Authors:  Monika Marcinkowska; Magdalena Kotańska; Agnieszka Zagórska; Joanna Śniecikowska; Monika Kubacka; Agata Siwek; Adam Bucki; Maciej Pawłowski; Marek Bednarski; Jacek Sapa; Małgorzata Starek; Monika Dąbrowska; Marcin Kołaczkowski
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.